SBHMY sino biopharmaceutical - trd205 granted breakthrough therapy designation by China's cde after phase II trial for cpsnp

SBHMY sino biopharmaceutical - trd205 granted breakthrough therapy designation by China's cde after phase II trial for cpsnp